Cite
SIRPαFc treatment targets human acute myeloid leukemia stem cells
MLA
Jean C.Y. Wang, et al. “SIRPαFc Treatment Targets Human Acute Myeloid Leukemia Stem Cells.” Haematologica, vol. 106, no. 1, Feb. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cd88cc3189829046a7aae01d09c087fd&authtype=sso&custid=ns315887.
APA
Jean C.Y. Wang, Robert A. Uger, Nathan Mbong, Liqing Jin, Jessica McLeod, Jayne S. Danska, James A. Kennedy, Mark D. Minden, Mark Wong, & Oleksandr Galkin. (2020). SIRPαFc treatment targets human acute myeloid leukemia stem cells. Haematologica, 106(1).
Chicago
Jean C.Y. Wang, Robert A. Uger, Nathan Mbong, Liqing Jin, Jessica McLeod, Jayne S. Danska, James A. Kennedy, Mark D. Minden, Mark Wong, and Oleksandr Galkin. 2020. “SIRPαFc Treatment Targets Human Acute Myeloid Leukemia Stem Cells.” Haematologica 106 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cd88cc3189829046a7aae01d09c087fd&authtype=sso&custid=ns315887.